The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...
The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...
Progesterone receptor (PR) signalling plays a multifaceted role in breast cancer, integrating genomic and non‐genomic pathways to influence tumour initiation, progression and therapeutic response. PR ...
A new research perspective was published in Oncotarget's Volume 14 on July 1, 2023, entitled, "Deciphering the mechanisms of action of progesterone in breast cancer." "This research perspective is ...
Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...
A special technique where breast cancer cells are "rescued" for research has been developed at the University of Adelaide. Coupled with advanced scientific technologies pioneered by Cambridge ...
A new analysis involving almost 10,000 women has shown that the added risk of breast cancer occurring under the age of 50 in association with oral contraceptive use was of similar magnitude regardless ...
Addition of progesterone leads to increased breast growth for those taking gender-affirming hormones
The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminising hormone therapy. This is demonstrated by an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results